Men's Rogaine is a drug owned by Johnson And Johnson Group Consumer Companies. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 20, 2019. Details of Men's Rogaine's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6946120 | Pharmaceutical composition |
Apr, 2019
(5 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Men's Rogaine is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Men's Rogaine's family patents as well as insights into ongoing legal events on those patents.
Men's Rogaine's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Men's Rogaine's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 20, 2019 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Men's Rogaine Generics:
There are no approved generic versions for Men's Rogaine as of now.
How can I launch a generic of Men's Rogaine before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Men's Rogaine's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Men's Rogaine's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Men's Rogaine -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 0.05 | 06 Apr, 2009 | 1 | 28 Apr, 2011 | 20 Apr, 2019 | Eligible |
| 0.05 | 04 Feb, 2015 | 1 | 27 Jul, 2017 | 20 Apr, 2019 | Eligible |
About Men's Rogaine
Men'S Rogaine is a drug owned by Johnson And Johnson Group Consumer Companies. It is used for hair regrowth. Men'S Rogaine uses Minoxidil as an active ingredient. Men'S Rogaine was launched by Johnson And Johnson in 2006.
Approval Date:
Men's Rogaine was approved by FDA for market use on 20 January, 2006.
Active Ingredient:
Men's Rogaine uses Minoxidil as the active ingredient. Check out other Drugs and Companies using Minoxidil ingredient
Treatment:
Men's Rogaine is used for hair regrowth.
Dosage:
Men's Rogaine is available in aerosol, foam form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 5% | AEROSOL, FOAM | Over the counter | TOPICAL |